Concepedia

Fengzhen Mo

FM

Statistics

Publications

13

Citations

485

H-Index

13

Active since

2017

Affiliations

Guangxi Medical University(Current)

Huazhong University of Science and Technology

Union Hospital

University of California, Davis

Tumor Hospital of Guangxi Medical University

Fengzhen Mo is an author at Guangxi Medical University specializing in medicine, t cell immunity, and immunology.

ORCID

Top concepts

Publications per year

2017–2023

13

Publications

13

The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide

Chunhui Lai, Siliang Duan, Fang Ye et al. · Theranostics · 2018 · 101 citations · Full text

Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy

Fengzhen Mo, Siliang Duan, Xiaobing Jiang et al. · Signal Transduction and Targeted Therapy · 2021 · 72 citations · Full text

Fusion of Dendritic Cells and Cancer-Associated Fibroblasts for Activation of Anti-Tumor Cytotoxic T Lymphocytes

Liwen Qian, Zhuoran Tang, Shihua Yin et al. · Journal of Biomedical Nanotechnology · 2018 · 45 citations

, , +23

<p>In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice</p>

Ziqiang Ding, Dujin Wang, Wei Shi et al. · International Journal of Nanomedicine · 2020 · 41 citations · Full text

A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine

Wei Shi, Xiaomei Yang, Shenxia Xie et al. · Cancer Letters · 2021 · 39 citations

, , +10

1–5 of 13